Evidence map›Paper›PMID 22275249›Full record

ArticleAnnals of neurology2012

KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.

Sarah Weckhuysen, Simone Mandelstam, Arvid Suls, Dominique Audenaert, Tine Deconinck, Lieve R F Claes, Liesbet Deprez, Katrien Smets, Dimitrina Hristova, Iglika Yordanova and 13 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Annals of neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 230 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
230citing papers in PubMed, 3 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

230 citing papers in PubMed, 3 syntheses or guidelines pooled it, 503 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Neurology. Genetics · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Mislocalization of KCNQ2 Channels as a Pathogenic Mechanism in KCNQ2 Developmental and Epileptic Encephalopathy.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

170 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 12 institutions in 5 countries.

Sarah WeckhuysenNeurogenetics Group, VIB-Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium.
Simone Mandelstam
Arvid Suls
Dominique Audenaert
Tine Deconinck
Lieve R F Claes
Liesbet Deprez
Katrien Smets
Dimitrina Hristova
Iglika Yordanova
Albena Jordanova
Berten Ceulemans
An Jansen
Danièle Hasaerts
Filip Roelens
Lieven Lagae
Simone Yendle
Thorsten Stanley
Sarah E Heron
John C Mulley
Samuel F Berkovic
Ingrid E Scheffer
Peter de Jonghe
VIB-UAntwerp Center for Molecular Neurology · BEUniversity of Antwerp · BEUniversity of Melbourne · AUAustin Health · AUKempenhaeghe · NLMedical University of Sofia · BGRoyal Children's Hospital · AUSouth Australia Pathology · AUTokuda Hospital · BGUniversity of Otago · NZUniversity of South Australia · AUVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveKCNQ2 and KCNQ3 mutations are known to be responsible for benign familial neonatal seizures (BFNS). A few reports on patients with a KCNQ2 mutation with a more severe outcome exist, but a definite relationship has not been established. In this study we investigated whether KCNQ2/3 mutations are a frequent cause of epileptic encephalopathies with an early onset and whether a recognizable phenotype exists.

methodsWe analyzed 80 patients with unexplained neonatal or early-infantile seizures and associated psychomotor retardation for KCNQ2 and KCNQ3 mutations. Clinical and imaging data were reviewed in detail.

resultsWe found 7 different heterozygous KCNQ2 mutations in 8 patients (8/80; 10%); 6 mutations arose de novo. One parent with a milder phenotype was mosaic for the mutation. No KCNQ3 mutations were found. The 8 patients had onset of intractable seizures in the first week of life with a prominent tonic component. Seizures generally resolved by age 3 years but the children had profound, or less frequently severe, intellectual disability with motor impairment. Electroencephalography (EEG) at onset showed a burst-suppression pattern or multifocal epileptiform activity. Early magnetic resonance imaging (MRI) of the brain showed characteristic hyperintensities in the basal ganglia and thalamus that later resolved.

interpretationKCNQ2 mutations are found in a substantial proportion of patients with a neonatal epileptic encephalopathy with a potentially recognizable electroclinical and radiological phenotype. This suggests that KCNQ2 screening should be included in the diagnostic workup of refractory neonatal seizures of unknown origin.

Indexed as

PhenotypeChildChild, PreschoolEpilepsy, Benign NeonatalFemaleHumansKCNQ2 Potassium ChannelMaleMutationKCNQ2 Potassium ChannelKCNQ2 protein, human

Identifiers

PMID22275249
OpenAlexW2112922820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.